Lilly pulls COVID-19 treatment from EU review while U.S. stocks up

Lilly pulls COVID-19 treatment from EU review while U.S. stocks up

Source: 
Reuters
snippet: 

Eli Lilly (LLY.N)has retracted a request for European Union approval of its antibody-based treatment for COVID-19, citing a lack of demand from EU member states as the bloc focuses on other suppliers.